PAX5 and leukemia: This suggests a BCR-ABL1+ precursor clone, which lacked PAX5 inactivation and RUNX1 mutation, independently gave rise to both Late-Pro leukemia at diagnosis and Early-Pro leukemia at relapse (Supplementary Fig. 19).